DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Orlando M, Chacón M, Salum G, Chacón DR.
Low-dose continuous oral fosfestrol is highly active in 'hormone-refractory' prostate cancer.
Ann Oncol 2000;
11: 177-81
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.